Karus has signed an agreement with a Chinese pharma company, licensing to them the rights to develop and commercialise KA2237 for the Greater China territory.
View Top Employees from Karus Therapeutics LimitedWebsite | http://www.karustherapeutics.com |
Revenue | $11 million |
Funding | $7.6 million |
Employees | 5 (5 on RocketReach) |
Founded | 2005 |
Phone | +44 1235 829140 |
Fax | +44 1235 420517 |
Technologies |
JavaScript,
HTML,
PHP
+6 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Healthcare, Science and Engineering, Drug Discovery, Drug Manufacturing & Research, Life Science, Pharmaceutical, Health Care |
Web Rank | 15 Million |
Keywords | Karus Therapeutics |
Competitors | ActivX Biosciences, GlycoMimetics, Mimetogen Pharmaceuticals Inc., Neuraltus Pharmaceuticals, OxStem Limited |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Karus Therapeutics Limited employee's phone or email?
The Karus Therapeutics Limited annual revenue was $11 million in 2023.
5 people are employed at Karus Therapeutics Limited.
The NAICS codes for Karus Therapeutics Limited are [32, 32541, 325, 3254].
The SIC codes for Karus Therapeutics Limited are [283, 28].